Sort
21,281 grants matching “influenza”
Innate and Acquired Immunity to Influenza Infection and Immunization
$405,664Harry Bernard Greenberg · Stanford University · U19 · FY2015 · AI
Core D: Bmem Analysis Core
$405,650Masayuki Kuraoka · Boston Children'S Hospital · P01 · FY2023 · AI
Core C - Modeling Core
$405,639Rafick-Pierre Sekaly · Icahn School Of Medicine At Mount Sinai · U19 · FY2022 · AI
Biology and infection of bats with novel bat influenza viruses
$405,576Wenjun Ma · University Of Missouri-Columbia · R01 · FY2022 · AI
IgA Protease as Therapy to Reverse IgA Nephropathy
$405,555Jiazhou Qiu · Igan Biosciences, Inc. · R44 · FY2011 · DK
Data Core RC2
$405,537Richard H Fortinsky · University Of Connecticut Sch Of Med/Dnt · P30 · FY2021 · AG
MIF and the Host Response to Infection
$405,516Richard J Bucala · Yale University · R01 · FY2012 · AI
MIF and the Host Response to Infection
$405,516Richard J Bucala · Yale University · R01 · FY2011 · AI
Novel vaccines for broad protection against avian influenza
$405,516John Rose · Yale University · R01 · FY2011 · AI
Novel vaccines for broad protection against avian influenza
$405,516John Rose · Yale University · R01 · FY2012 · AI
Novel disposable microchips for HIV-1 viral load
$405,334Utkan Demirci · Stanford University · R01 · FY2015 · AI
Project 2
$405,310Jeroen Roose · University Of California, San Francisco · P01 · FY2020 · AI
Understanding T cell responses and T cell signaling in human airway organoids with SARS-CoV-2 infection
$405,310Arthur Weiss · University Of California, San Francisco · P01 · FY2020 · AI
A chikungunya Viral Replicon as a Platform for Antiviral Therapeutics
$405,108David E. Levy · Columbia University Health Sciences · U54 · FY2011 · AI
Overcoming host Genetic Redundancy and Pathogen Subversion to Define new host-viral Interfaces
$405,071Robert C. Orchard · Ut Southwestern Medical Center · R35 · FY2024 · GM
Overcoming host Genetic Redundancy and Pathogen Subversion to Define new host-viral Interfaces
$405,071Robert C. Orchard · Ut Southwestern Medical Center · R35 · FY2021 · GM
Overcoming host Genetic Redundancy and Pathogen Subversion to Define new host-viral Interfaces
$405,071Robert C. Orchard · Ut Southwestern Medical Center · R35 · FY2023 · GM
Overcoming host Genetic Redundancy and Pathogen Subversion to Define new host-viral Interfaces
$405,071Robert C. Orchard · Ut Southwestern Medical Center · R35 · FY2022 · GM
Overcoming host Genetic Redundancy and Pathogen Subversion to Define new host-viral Interfaces
$405,071Robert C. Orchard · Ut Southwestern Medical Center · R35 · FY2025 · GM
Role of DM in Generation of Immunodominant Epitope(s)
$405,000Scheherazade Sadegh-Nasseri · Johns Hopkins University · R01 · FY2015 · AI
Structure and Regulatory Mechanisms of the Vacuolar ATPase
$405,000Stephan Wilkens · Upstate Medical University · R35 · FY2025 · GM
Polypeptide Hybrid Particles and Their Constituents
$405,000Paul S Russo · Louisiana State University · · FY2013 · MPS
Influenza A Virus Infection of Human Nasal Epithelial Cells
$405,000Andrew S. Pekosz · Johns Hopkins University · R01 · FY2012 · AI
Monoclonal Antibody Technology Core
$405,000Patrick Christopher Wilson · Icahn School Of Medicine At Mount Sinai · P01 · FY2021 · AI
The use of genetically humanized IL-10 mice to determine the molecular basis of a
$405,000Jay H. Bream · Johns Hopkins University · R01 · FY2015 · AI